Avidity Biosciences
La Jolla, US · Founded 2012 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
Avidity Biosciences was founded in 2012 by Troy Wilson PhD., JD and P. Kent Hawryluk.
TW
Troy Wilson PhD., JDCo-founder
PK
P. Kent HawrylukCo-founder
ME
Mark E. DavisNamed on SEC filing
FM
Frank McCormickNamed on SEC filing
TW
Troy WilsonNamed on SEC filing
Board
TB
MM
Michael Martin PhD.Board director
Investors · 2
Reported raises · per SEC filings
Form D private placements$527.8M disclosed across 4 rounds · 2014–2024
▶$400.2MraisedMar 2024 · 45 investors · BiotechnologyRule 506(b)
▶$400.2MraisedMar 2024 · 45 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Noreen HenigDirector
- Carsten BoessDirector
- Troy WilsonDirector
- Tamar ThompsonDirector
- Sarah BoyceExecutive Officer, Director
- Teresa McCarthyExecutive Officer
- Edward KayeDirector
- Jean KimDirector
- W. Michael FlanaganExecutive Officer
- Arthur LevinExecutive Officer
- Michael MacLeanExecutive Officer
- Offering amount
- $400.2M
- Amount sold
- $400.2M
- Sales commissions
- $20M
- Placement agents
- Chardan Capital Markets, LLC, BofA Securities Inc., Leerink Partners LLC, Cantor Fitzgerald & Co.
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100.5MraisedNov 2019 · 28 investors · BiotechnologyRule 506(b)
▶$100.5MraisedNov 2019 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL MARTINDirector
- TODD BRADYDirector
- EDWARD KAYEDirector
- RODERICK WONGDirector
- NOREEN HENIGDirector
- TROY WILSONDirector
- SARAH BOYCEExecutive Officer, Director
- Offering amount
- $103.8M
- Amount sold
- $100.5M
- Sales commissions
- $2.7M
- Placement agents
- SVB Leerink LLC
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$18MraisedJan 2017 · 21 investors · BiotechnologyRule 506(b)
▶$18MraisedJan 2017 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Troy Wilson PhD., JDExecutive Officer, Director
- P. Kent HawrylukExecutive Officer
- Todd BradyDirector
- Michael Martin PhD.Director
- Offering amount
- $23.3M
- Amount sold
- $18M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$9.1MraisedFeb 2014 · 36 investors · BiotechnologyRule 506(b)
▶$9.1MraisedFeb 2014 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark E. DavisDirector
- Frank McCormickDirector
- P. Kent HawrylukExecutive Officer
- Troy WilsonExecutive Officer, Director
- Offering amount
- $9.1M
- Amount sold
- $9.1M
- First sale
- Jan 2014
- Incorporated
- Limited Liability Company, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Avidity Biosciences?
- Avidity Biosciences was founded by Troy Wilson PhD., JD, P. Kent Hawryluk in 2012.
- Who are Avidity Biosciences's investors?
- Avidity Biosciences's investors include Brace Pharma, Frazier Life Sciences.
- How much funding has Avidity Biosciences raised?
- Avidity Biosciences has disclosed $527.8M raised across 4 rounds.
- Where is Avidity Biosciences headquartered?
- Avidity Biosciences is headquartered in La Jolla, US.